CytRx Corp (NASDAQ:CYTR)

3.98
Delayed Data
As of May 28
 -0.02 / -0.50%
Today’s Change
2.08
Today|||52-Week Range
5.46
+45.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$222.9M

Company Description

CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. The company on the clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. CytRx was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Contact Information

CytRx Corp.
11726 San Vicente Boulevard
Los Angeles California 90049
P:(310) 826-5648
Investor Relations:

Employees

Shareholders

Individual stakeholders9.88%
Other institutional25.97%
Mutual fund holders11.66%

Top Executives

Steven A. KriegsmanPresident, Chief Executive Officer & Director
John Y. CalozChief Financial Officer & Treasurer
Daniel J. LevittChief Medical Officer & Executive Vice President
David J. HaenVP-Business Development & Head-Investor Relations
Douglas Scott WielandSenior Vice President-Drug Development

To view my watchlist

Not a member yet?

Sign up now for a free account